Penetration of ceftriaxone (1 or 2 grams intravenously) into mediastinal and cardiac tissues in humans

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 812-815

  Martin, Claude ^a   Viviand, Xavier ^a   Alaya, Majed ^b   Lokiec, François ^c   Ennabli, Karim ^b   Said, Rachid ^b   Pecking, Michèle ^d  

^a HÔPITAL NORD   (France)

^b SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

^c CENTRE RENÉ HUGUENIN   (France)

^d Produits Roche   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG PENETRATION; HEART MUSCLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MEDIASTINUM; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS; SERUM BACTERICIDAL ACTIVITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TISSUE DISTRIBUTION;

EID: 0030029999     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.812     Document Type: Article

References (25)

1. Bayer, A. S., R. J. Nelson, and G, T. Slama. 1990. Current concepts in prevention of prosthetic valve endocarditis Chest 97:1203-1207.
2. Beam, T. R., T. A. Raab, J. A. Spooner, S. C. Balderman, J. Aldridge and J. N. Bahyana. 1984. Comparison of ceftriaxone and cefazolin prophylaxis against infection in open heart surgery. Am. J Surg 213:9-14
3. Bergamini, T. M., and M. C. Polk. 1989. The importance of tissue antibiotic activity in the prevention of operative wound infection. J. Antimicrob Chemother. 23:301-313.
4. Brodgen, R. N., and A. Ward. 1988. Ceftriaxone: a reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration. Drugs 35:604-645.
5. Burke, J. F. 1961. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 50:161-168.
6. Classen, D. C., R. S. Evans, S. L. Pestonik, S. D. Horn, R. L. Menlove, and J. P. Burke. 1992 The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N. Engl. J. Med. 326:281-286.
7. Dasta, J. F., J. Jacobi, L. S. Wu, T. Sokoloski, P. Beckley, T. E. Reilley, and M. B. Howie. 1983 Loss of nitroglycerin to cardiopulmonary bypass apparatus. Crit. Care Med. 11:50-52.
8. Geroulanos, S., B. Donfried, and M. Turina. 1984. Plasma levels of ceftriaxone in cardiovascular surgery. Am. J. Surg, 213:5-7.
9. Jungbluth, G. L., M. T. Pasko, T. R. Beam, and W. J. Jusko 1989. Ceftriaxone disposition in open-heart surgery patients. Antimicrob. Agents Chemother. 33:850-856
10. Kaiser, A. B. 1986. Antimicrobial prophylaxis in surgery. N. Engl. J. Med. 315:1129-1138.
11. Klamerus, K. J., K. A. Rodvold, N. A. Silverman, and S. Levitsky. 1988. Effect of cardiopulmonary bypass on vancomycin and netilmicin disposition. Antimicrob Agents Chemother. 32:631-635.
12. Knapp, C. C., J. Sierra-Madero, and J. A. Washington. 1988 Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone. Antimicrob Agents Chemother. 32:1896-1898.
13. Koren, G., P. Crean, J. Klein, G. Goresky, J. Villamater, and S. M. MacLeod. 1984. Sequestration of fentanyl by the cardiopulmonary bypass (CPB). Eur. J. Pharmacol. 27:53-56.
14. Martin, C. 1994. Antimicrobial prophylaxis in surgery: general concepts and clinical guidelines. Infect. Control Hosp. Epidemiol. 7:463-471.
15. Martin, C., M. Alaya, M.-N. Mallet, X. Viviand, K. Ennabli, R. Said, and P. De Micco. 1994. Penetration of vancomycin into mediastinal and cardiac tissues in humans. Antimicrob. Agents Chemother. 38:396-399
16. Martin, C., J. Kagni, F. Lokiec, J. C. Guillen, A. Auge, M. Pecking, and F. Gouin. 1992. Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 mg intravenously) for antibiotic prophylaxis in thoracic surgery. Antimicrob. Agents Chemother. 36:2804-2807.
17. Mutch, D. G., R. A. Richards, and D. S. Mudler. 1982. Bioactive antibiotic levels in the human aorta. Surgery 92:1068-1071.
18. Pitkin, D. M., C. Sachs, I. Zajac, and P. Actor. 1977. Distribution of sodium cefazolin in serum, muscle, bone marrow, and bone of normal rabbits. Antimicrob Agents Chemother. 11:760-762.
19. Stanbridge, T. N., and D. J. Greenall. 1984. Netilmicin prophylaxis in openheart surgery. J. Antimicrob. Chemother. 13(Suppl. A):59.
20. Stone, H. H. 1984. Basic principles in the use of prophylactic antibiotics J Antimicrob. Chemother. 14(Suppl. B):33-37.
21. Stratton, C. W., C. Liu, and L. S. Weeks. 1987. Activity of LY146032 compared with that of methicillin. cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vaneumycin against staphylococci as determined by kill-kinetic studies. Antimicrob. Agents Chemother. 31:1210-1215.
22. Trautmann, K. H., and I. Haeffelfinger. 1981. Determination of the cephalosporin RO 13-9904 in plasma, urine and bile by means of ion-pair reversed phase chromatography. J. High Resolut. Chromatogr. 4:54-59.
23. Urien, S. 1992 Micropharm: software designed to simulate and analyse experimental data in biology, abstr. 12. In Proceedings of the International Conference on Research in Computer Science and Control
24. Wagner, J. G. 1975. Fundamentals of clinical pharmacokinetics. p. 217-231. Drug Intelligence Publications. Hamilton, Ontario, Canada.
25. Washington, J. A. 1979 The effects and significance of subminimal inhibitory concentrations of antibiotics. Rev. Infect. Dis. 1:781-786.